# Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients

> **NCT02970747** · — · COMPLETED · sponsor: **iOMEDICO AG** · enrollment: 359 (actual)

## Conditions studied

- Multiple Myeloma in Relapse

## Interventions

- **DRUG:** Carfilzomib

## Key facts

- **NCT ID:** NCT02970747
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-25
- **Primary completion:** 2025-04-26
- **Final completion:** 2025-04-26
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970747, "Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02970747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*